The global cardiac holter monitor market size was significantly large in 2022, and is expected to continue to register a rapidly inclining revenue CAGR between 2023 and 2032. Key factors responsible for driving market revenue growth are increasing public awareness of the benefits of using a cardiac holter monitor and rising prevalence of cardiovascular diseases among people across the globe.
Increasing number of patients suffering from cardiovascular disorders, surging usage of wireless holter monitors, and rising government investments in research and development activities are anticipated to propel growth of the cardiac holter monitor market in the upcoming years. On the other hand, technological advancements, as well as rising demand for preventive and diagnostic healthcare, will create various opportunities for the cardiac holter monitor market to grow during the forecast period.
Request a Sample@ https://www.qyresearchmedical.com/sample/119407
Major Factors Driving Growth of The Global Cardiac Holter Monitor Market:
According to the World Health Organization (WHO), Cardiovascular Disease (CVD) is the leading cause of death worldwide, with approximately 30 million people experiencing a heart attack or stroke each year. The American Heart Association also stated that nearly half of all adults in the United States suffer from cardiovascular disease. CVD is expected to affect more than 130 million adults, or 45.1 percent of the U.S. population, by 2035. Family history, ethnicity, and age are some of the important risk factors for CVD. Tobacco use, high blood pressure (hypertension), high cholesterol, obesity, inactivity, diabetes, and unhealthy diets are some of the other risk factors.
Moreover, pre-monitoring and pre-diagnosis can prevent the majority of CVDs. Arrhythmias, which is referred to as abnormalities in the heart\’s function, can also be avoided with early detection. As a result, demand for cardiac holter monitors is rising, as these devices can help save patients who are at high risk of cardiac arrest. These factors are anticipated to propel the cardiac holter monitor market growth in the near future.
Factors Restraining Growth Of The Global Cardiac Holter Monitor Market:
Patients and healthcare providers are concerned about cybersecurity vulnerabilities in medical devices, particularly cardiac holter monitors, which have the potential to be reprogrammed or rendered nonfunctional. Serious cybersecurity vulnerability may allow an attacker with sophisticated insider knowledge to harm a patient by altering programming on an implanted defibrillator. The U.S. Food and Drug Administration (FDA), for instance, recalled nearly 500,000 implantable pacemakers in 2017 due to potential for hacking. As a result, the market\’s growth is limited to some extent.
Opportunities For Players Operating In The Global Cardiac Holter Monitor Market:
Cardiac holter monitors have been linked to improved survival and quality of life when these are used to treat cardiac arrhythmias. Infections associated with the use of these devices, on the other hand, are a major complication. Infections with cardiac holter monitors are most common in people who have an implantable cardioverter-defibrillator or a cardiac resynchronization therapy defibrillator. According to the European Heart Journal, pacemakers had a 1.19 percent infection rate, implantable cardioverter-defibrillators had a 1.91 percent infection rate, cardiac resynchronization therapy pacemakers (CRT-Ps) had a 2.18 percent infection rate, and CRT defibrillators had a 3.35 percent infection rate (CRTDs).
To improve stabilization of cardiac holter monitors in subcutaneous pocket and elute antibiotics minocycline and rifampin, companies are striving to develop state-of-the-art products. These products are being developed for cardiac implantable electronic devices, such as cardiac holter monitors, namely, pacemakers and Implantable Cardioverter Defibrillators (ICDs).
Global Cardiac Holter Monitor Market Revenue Led By Product Segment:
Based on product, the cardiac holter monitor market is segmented into wired holter ECG monitor and wireless holter ECG monitor. The wireless ECG monitor segment held the largest share of the market in 2020. Technological advancements, such as incorporation of advanced algorithms and workflow improvement features, namely, simplified operations, touchscreen systems, portability, wireless features, and better connectivity with Cardiovascular Information Systems (CVIS), electronic medical records (EMRs), and ECG management systems, are responsible for the large share of this segment.
Global Cardiac Holter Monitor Market Leading End-use Segment:
Based on end-use, the cardiac holter monitor market is segmented into hospitals & clinics, Ambulatory Surgery Centers (ASCs), and homecare. Out of these, the hospitals & clinics held the largest market share in 2020, owing to rising number of cardiac implant procedures, increasing prevalence of cardiovascular diseases, availability of favorable reimbursement policies for these procedures, and rising number of patient visits to hospitals & clinics for diagnosis across developed and developing countries.
North America Accounts For Largest Revenue Share In Global Cardiac Holter Monitor Market:
The cardiac holter monitor market in North America is anticipated to generate the largest revenue share in the forthcoming years, owing to rising prevalence of cardiovascular diseases and increasing geriatric population in the region.
Asia Pacific Continues To Lead In Terms Of Revenue CAGR:
The cardiac holter monitor market in Asia Pacific is expected to grow at the fastest rate due to increasing technological advancements, improved healthcare infrastructures, and rising incidence of cardiovascular disease in this region. Latin America and the Middle East and Africa, on the other hand, are expected to grow at a slower-to-moderate pace. Presence of prominent companies and increased awareness of the need for cardiac monitoring are expected to propel growth in both regions in the near future.
Major Companies Profiled in The Report:
- Boston Scientific
- Abbott Laboratories
- GE Healthcare
- Koninklijke Philips
- Asahi Kasei Corporation
- MicroPort Scientific Corporation
- Hill-Rom Holdings
- Nihon Kohden
- SCHILLER AG
- BPL Medical Technologies
- ACS Diagnostic
- Shenzhen Mindray Bio-Medical Electronics
- Lepu Medical Technology
- Shree Pacetronix
- BTL t
- Alivecor Inc.
- Bexen Cardio
- Narang Medical Limited
- MeTrax GmbH
- Progetti Srl
Strategies And Objectives Of Major Companies:
- Gallant, an Implantable Cardioverter Defibrillator (ICD), will be available in Europe in 2020, according to Abbott Laboratories.
- Cardiac Science, a leading provider of AEDs, related services, and accessories, was acquired by ZOLL Medical (an Asahi Kasei Group Company) in 2019. ZOLL Medical\’s position in the AED market has been strengthened as a result of this acquisition.
- In 2023, the MoMe Kardia external cardiac diagnostic monitor from InfoBionic was made available exclusively through BIOTRONIK in the United States. This has aided the company in expanding its cardiovascular solution portfolio to assist physicians in providing the best care as quickly and efficiently as possible.
- Nihon Kohden opened a sales branch in Kenya in 2017. This initiative has contributed to the company\’s ability to maintain a strong customer base in the Middle East and Africa.
What Our Report Provides And Why Our Offering Is Better:
This report offers historical data points and forecasts and revenue growth at a global, regional, and country level, and provides analysis, industry trends, and consumption pattern details for each region, major country, and segment from 2023 to 2032. The global market report includes industry trends, drivers, restraints, opportunities, threats, market strategies, segment revenue, and market share contribution by each regional and country market. In addition, the report offers industry analysis and competitive landscape, company financials, and impact analysis. The report includes a detailed view of the global market, along with changing dynamics and trends, scenarios, detailed market and regional segmentation, regional landscape, analysis and evaluation, major investments, product offerings, product launches, and details of historical, current, and projected revenues.
Detailed Segmentation In Our Report:
For the purpose of this report, global cardiac holter monitor market is segmented on the basis of product, lead type, end-use, and region:
Product Outlook (Revenue, USD Billion; 2023-2032)
- Wired Holter ECG Monitor
- Wireless Holter ECG Monitor
Lead type Outlook (Revenue, USD Billion; 2023-2032)
- 1 Lead Holter Monitor
- 3 Lead Holter Monitor
- 6 Lead Holter Monitor
- 12 Lead Holter Monitor
End-use Outlook (Revenue, USD Billion; 2023-2032)
- Hospitals & Clinics
- Ambulatory Surgical Centers (ASC)
Region Outlook (Revenue, USD Billion; 2023-2032)
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Buy quantitative research Report at discounted price – USD 1500 https://www.qyresearchmedical.com/report/checkout/119407/1500
You can place an order or ask any questions, please feel free to contact email@example.com | +1 9197 992 333
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us: